ロード中...
Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
CD46 is a complement inhibitor membrane cofactor which also acts as a receptor for various microbes, including species B adenoviruses (Ads). While most Ad gene therapy vectors are derived from species C and infect cells through coxsackie-adenovirus receptor (CAR), CAR expression is downregulated in...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122383/ https://ncbi.nlm.nih.gov/pubmed/27203670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9427 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|